Based in Atlanta, the French Family Foundation seeks to enhance children’s lives by providing access to quality education, breaking the cycle of poverty, and improving technical & financial literacy.
The French Family Foundation also seeks to support medical research to discover a cure for patients stricken with Myelodysplastic Syndrome or Acute Myeloid Leukemia (AML) with a TP53 mutation.
A quality education is essential to leading a productive & successful life in today’s global economy. Poor educational skills lead to poor financial and societal outcomes.
In order for capitalism to flourish in a democracy, all citizens must have access to upward financial mobility through hard work. Without mobility based on merit, democracies will ultimately constrain the productive capacity of capitalism.
In the 21st Century workplace, technical skills are a requirement for success. Unfortunately, they are also often overlooked by American educational institutions. Today, many young people lack the core financial skills necessary to manage their lives effectively.
MDS/AML with a TP53 mutation is one of the most difficult to treat blood cancers despite many decades of research to find durable therapeutics.
Sarah French passed away from AML with a TP53 mutation at the age of 50 in 2022.
We have partnered with the Leukemia & Lymphoma Society (LLS) to jointly fund research projects seeking therapeutics for MDS/AML with a TP53 mutation.
French Family Foundation
The French Family Foundation was founded in 2019 by Sarah and Reid French of Atlanta, Georgia. It is the primary charitable vehicle for the family and was established at the same time as the creation of their family office, Essex Gate Ventures.
Essex Gate Ventures
Essex Gate Ventures focuses primarily on technology investments, with a particular investment theme of B2B cloud software businesses. The family office invests in this sector through direct private investments, private equity, and public equity.
More information regarding Essex Gate Ventures can be found here.